The long term objectives of this proposal are (1) to improve the effectiveness of currently useful anticancer compounds such as AraC and hydroxyurea (HU) by studying the detailed mechanisms of action and resistance, (2) to identify new targets for the development of new protocols or new anticancer agents by studying the properties of enzymes involved in DNA synthesis. Three areas of investigation are proposed: The first part, it to investigate the possible new targets of deoxynucleoside analog action. In addition to providing new knowledge for understanding enzymes involved in DNA metabolism, such as """"""""AraC-DNase"""""""", DNA polymerase Alpha activators, DNA primase, and DNA topoisomerase, this study will also aid in studying the biochemical determinants and the mechanism of cell resistance to araC, which is the second part of the proposal. One of the biochemical determinants of deoxynucleoside analogs, such as araC, is the intracellular content of deoxynucleoside triphosphates (dNTP). Ribonucleotide reductase (RR), the target of HU action, is the key enzyme for dNTP de novo synthesis. In order to study the regulation of deoxynucleotides and their relationship to the action of deoxynucleoside analogs, human cell lines with different activity or regulation of RR will be useful. HU was therefore used to select those cell lines. The characterization of those cell lines constitutes the third part of this proposal. This study will provide not only the basic knowledge of the regulation of deoxynucleotides which is important in understanding deoxynucleoside analog action, but also the mechanism of the resistance to HU. Through a clear understanding of the mechanism of resistance to drugs, collaterally sensitive compounds could be chosen based on these unique mechanisms of drug resistance. Furthermore, we will continue to interact with medicinal chemistry laboratories and to serve as a resource for the study of new nucleoside analogs synthesized by them, and to participate in clinical protocol design based on our understanding of drug action.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA027448-09
Application #
3167650
Study Section
(SSS)
Project Start
1979-05-01
Project End
1988-02-29
Budget Start
1987-03-01
Budget End
1988-02-29
Support Year
9
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
Schools of Medicine
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Rose, K M; Szopa, J; Han, F S et al. (1988) Association of DNA topoisomerase I and RNA polymerase I: a possible role for topoisomerase I in ribosomal gene transcription. Chromosoma 96:411-6
Cheng, Y C; Dutschman, G E; Bastow, K F et al. (1987) Human immunodeficiency virus reverse transcriptase. General properties and its interactions with nucleoside triphosphate analogs. J Biol Chem 262:2187-9
Parker, W B; Cheng, Y C (1987) Inhibition of DNA primase by nucleoside triphosphates and their arabinofuranosyl analogs. Mol Pharmacol 31:146-51
Starnes, M C; Cheng, Y C (1987) Cellular metabolism of 2',3'-dideoxycytidine, a compound active against human immunodeficiency virus in vitro. J Biol Chem 262:988-91
Brixner, D I; Ueda, T; Cheng, Y C et al. (1987) Folate analogues as inhibitors of thymidylate synthase. J Med Chem 30:675-8
Townsend, A J; Cheng, Y C (1987) Sequence-specific effects of ara-5-aza-CTP and ara-CTP on DNA synthesis by purified human DNA polymerases in vitro: visualization of chain elongation on a defined template. Mol Pharmacol 32:330-9
Bone, R; Cheng, Y C; Wolfenden, R (1986) Inhibition of thymidine kinase by P1-(adenosine-5')-P5-(thymidine-5')-pentaphosphate. J Biol Chem 261:5731-5
Bone, R; Cheng, Y C; Wolfenden, R (1986) Inhibition of adenosine and thymidylate kinases by bisubstrate analogs. J Biol Chem 261:16410-3
Thurston, L S; Irie, H; Tani, S et al. (1986) Antitumor agents. 78. Inhibition of human DNA topoisomerase II by podophyllotoxin and alpha-peltatin analogues. J Med Chem 29:1547-50
Townsend, A; Leclerc, J M; Dutschman, G et al. (1985) Metabolism of 1-beta-D-arabinofuranosyl-5-azacytosine and incorporation into DNA of human T-lymphoblastic cells (Molt-4). Cancer Res 45:3522-8